Edwards Lifesciences (EW) Total Current Liabilities (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Total Current Liabilities of $1.4 billion for Q1 2026, up 1.02% year-over-year from $1.4 billion in Q1 2025, and down 22.31% quarter-over-quarter from $1.8 billion in Q4 2025.
Edwards Lifesciences (EW) Total Current Liabilities (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Total Current Liabilities history runs 18 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 1.02% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (up 1.02% YoY), while the FY2025 annual figure was $1.8 billion, up 20.5% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $1.4 billion, down from $1.8 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $1.9 billion in Q3 2024, with the low at $917.9 million in Q3 2022.
- The 5-year median for Total Current Liabilities is $1.2 billion (2024), against an average of $1.3 billion.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities surged 56.92% in 2024, then decreased 18.32% in 2025.
- Edwards Lifesciences' Total Current Liabilities stood at $1.0 billion in 2022, then gained by 16.92% to $1.2 billion in 2023, then rose by 25.92% to $1.5 billion in 2024, then increased by 20.5% to $1.8 billion in 2025, then dropped by 22.31% to $1.4 billion in 2026.
- Business Quant data shows EW's Total Current Liabilities at $1.4 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 3.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Bn |
| Mar 31, 2026 | 1.41 Bn |
| Dec 31, 2025 | 1.81 Bn |
| Sep 30, 2025 | 1.59 Bn |
| Jun 30, 2025 | 1.40 Bn |
| Mar 31, 2025 | 1.39 Bn |
| Dec 31, 2024 | 1.51 Bn |
| Sep 30, 2024 | 1.94 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.11 Bn |
| Dec 31, 2023 | 1.20 Bn |
| Sep 30, 2023 | 1.24 Bn |
| Jun 30, 2023 | 1.16 Bn |
| Mar 31, 2023 | 1.08 Bn |
| Dec 31, 2022 | 1.02 Bn |
| Sep 30, 2022 | 917.90 Mn |
| Jun 30, 2022 | 969.10 Mn |
| Mar 31, 2022 | 949.90 Mn |
| Dec 31, 2021 | 1.03 Bn |
| Sep 30, 2021 | 966.50 Mn |